Gastric cancer is one of the most common malignant tumors in the digestive system in China. Few comprehensive practice guidelines for early gastric cancer in China are currently available. Therefore, we created the Chinese national clinical practice guideline for the prevention, diagnosis, and treatment ...
Black, Christopher;
Paine, Peter;
Agrawal, Anurag;
Aziz, Imran;
Eugenicos, Maria;
Houghton, Lesley;
Hungin, Pali;
Overshott, Ross;
Rudd, Sheryl;
Corsetti, Maura;
Ford, Alexander.
Functional dyspepsia (FD) is a common disorder of gut–brain interaction, affecting approximately 7% of individuals in the community, with most patients managed in primary care. The last British Society of Gastroenterology (BSG) guideline for the management of dyspepsia was published in 1996. In the int...
The purpose of this Clinical Practice Update Expert Review is to provide clinicians with guidance on the diagnosis and management of atrophic gastritis, a common preneoplastic condition of the stomach, with a primary focus on atrophic gastritis due to chronic Helicobacter pylori infection-the most common...
Gastritis, Atrophic/diagnostic imaging,
Gastritis, Atrophic/prevention & control,
Endoscopy, Digestive System,
Neuroendocrine Tumors/virology,
Helicobacter pylori/virology,
Precancerous Conditions,
Stomach/injuries,
Helicobacter Infections/diagnosis
La infección por Helicobacter pylori (HP) es la infección crónica más común en humanos (1, 2).
Se trata de una bacteria gram negativa espiralada, microaerofílica (3) que por su contenido en
ureasa, motilidad y capacidad para adherirse al epitelio gástrico puede sobrevivir y proliferar en
el medio ...
This guideline covers investigating and managing gastro-oesophageal reflux disease (GORD) and dyspepsia in people aged 18 and over. It aims to improve the treatment of GORD and dyspepsia by making detailed recommendations on Helicobacter pylori eradication, and specifying when to consider laparoscopic fu...
Carmona-Sánchez, R;
Gómez-Escudero, O;
Zavala-Solares, M;
Bielsa-Fernández, MV;
Coss-Adame, E;
Hernández-Guerrero, AI;
Huerta-Iga, F;
Icaza-Chávez, ME;
Lira-Pedrín, MA;
Lizárraga-López, JA;
López-Colombo, A;
Noble-Lugo, A;
Pérez-Manauta, J;
Raña-Garibay, RH;
Remes-Troche, JM;
Tamayo, JL;
Uscanga, LF;
Zamarripa-Dorsey, F;
Valdovinos Díaz, MA;
Velarde-Ruiz Velasco, JA.
Desde la publicación de las guías de dispepsia 2007 de la Asociación Mexicana de Gastroenterología ha habido avances significativos en el conocimiento de esta enfermedad. Se realizó una revisión sistemática de la literatura en PubMed (01/2007 a 06/2016) con el fin de revisar y actualizar las guía...
Dyspepsia,
Helicobacter pylori/drug effects,
Helicobacter Infections,
Dyspepsia/drug therapy,
Dyspepsia/epidemiology,
Dyspepsia/diagnosis,
Dyspepsia/therapy,
Helicobacter Infections/diagnosis,
Helicobacter Infections/therapy,
Endoscopy, Gastrointestinal
Jones, N. L;
Koletzko, S;
Goodman, K;
Bontems, P;
Cadranel, S;
Casswall, T;
Czinn, S;
Gold, B. D;
Guarner, J;
Elitsur, Y;
Homan, M;
Kalach, N;
Kori, M;
Madrazo, A;
Megraud, F;
Papadopoulou, A;
Rowland, M.
BACKGROUND: Because of the changing epidemiology of Helicobacter pylori infection and low efficacy of currently recommended therapies, an update of the European Society for Paediatric Gastroenterology Hepatology and Nutrition/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition...
Gisbert, JP;
Molina-Infante, J;
Amador, J;
Bermejo, F;
Bujanda, L;
Calvet, X;
Castro-Fernández, M;
Cuadrado-Lavín, A;
Elizalde, JI;
Gene, E;
Gomollón, F;
Lanas, Á;
Martín de Argila, C;
Mearin, F;
Montoro, M;
Pérez-Aisa, Á;
Pérez-Trallero, E;
McNicholl, AG.
Helicobacter pylori approximately infect 50% of Spanish population and causes chronic gastritis, peptic ulcer and gastric cancer. Until now, three consensus meetings on H.pylori infection had been performed in Spain (the last in 2012). The changes in the treatment schemes, and the increasing available ev...
Anti-Bacterial Agents/therapeutic use,
Proton Pump Inhibitors/therapeutic use,
Bismuth/therapeutic use,
Algorithms,
Delphi Technique,
Drug Therapy, Combination,
Gastritis/complications,
Helicobacter Infections,
Helicobacter pylori,
Probiotics,
Proton Pump Inhibitors,
Recurrence,
Salvage Therapy,
Stomach Neoplasms,
Stomach Ulcer,
Treatment Failure,
Gastritis/drug therapy,
Helicobacter Infections/drug therapy,
Helicobacter pylori/drug effects
Objetivo: brindar una guía de práctica clínica basada en la evidencia más reciente para el diagnóstico y tratamiento de la infección por Helicobacter pylori teniendo en cuenta la efectividad y seguridad de las intervenciones dirigidas a pacientes, personal asistencial, administrativo y entes gubern...
